Noteworthy

Apr 01, 2011
Pharmaceutical Executive
A true performance culture has to focus on the mundane as much as the sublime
Apr 01, 2011
Pharmaceutical Executive
By Pharmaceutical Executive Editors
The determination of Pfizer's Freda Lewis-Hall has enabled her to find a ray of hope in every situation she's encountered
Apr 01, 2011
Pharmaceutical Executive
By Pharmaceutical Executive Editors
It can take both a clinical and non-clinical approach to win the differentiation competition
Apr 01, 2011
Pharmaceutical Executive
By Pharmaceutical Executive Editors
GSK's Deirdre Connelly puts the focus on four steps to cement a new compliance culture
Apr 01, 2011
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Pfizer's Sarah Krug describes what's necessary to bridge the gap between the patient revolution and healthcare provider in the 21st century
Apr 01, 2011
Pharmaceutical Executive
William Looney, Editor-in-Chief, last month took home the award for "Best Commentary"
Apr 01, 2011
Pharmaceutical Executive
Dutch-based DSM N.V. is seeking innovatinve ways to partner through bolstering manufacturing
Mar 01, 2011
Pharmaceutical Executive
Can PhRMA's own business model synch with industry's Pharm Exec takes a closer look at PhRMA's new leadership.
Mar 01, 2011
Pharmaceutical Executive
By Pharmaceutical Executive Editors
A sneak preview of The Avoca Group's 2011 Annual Survey on CRO and Industry Relationships
Mar 01, 2011
Pharmaceutical Executive
By Pharmaceutical Executive Editors
The Federal Circuit court continues its trend in tightening the standards for establishing patent damages by leapfrogging a stalled legislative process
native1_300x100
lorem ipsum